Brand-Specific Enhanced Safety Surveillance Study of GSK’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season
Gaël Dos Santos(Universidade Federal de Campina Grande), Ugo Nwoji(GlaxoSmithKline (United States)), Maria Rybo, Muriel Soler, Xavier Martínez‐Gómez(Vall d'Hebron Hospital Universitari), Ignacio Salamanca de la Cueva(Instituto Hispalense de Pediatria), Hélène Roul, Tamara Eckermann, Sridevi Pallem(Enzo Life Sciences (United States)), Éric Godard, Hao Wang(GGD Amsterdam), Pooja Jindal(All India Institute of Medical Sciences Raipur), Mitra Yousefi(GlaxoSmithKline (United States)), Lode Godderis(KU Leuven)
Cited by 6
Related Papers
How much do resin-based dental materials release? A meta-analytical approach
|Dental Materials|2011|458
Recommendations for screening, monitoring, prevention, and prophylaxis of infections in adult and pediatric patients receiving CAR T-cell therapy: a position paper
|Infection|2020|143
Agglomeration of titanium dioxide nanoparticles increases toxicological responses in vitro and in vivo
|Particle and Fibre Toxicology|2020|121
Long-term elution of monomers from resin-based dental composites
|Dental Materials|2019|96
The Effects of <i>GSTM1</i> and <i>GSTT1</i> Polymorphisms on Micronucleus Frequencies in Human Lymphocytes <i>In vivo</i>
|Cancer Epidemiology Biomarkers & Prevention|2006|90